About Gaize
Cannabis is getting legalized; we’re making sure it’s done safely.
It’s undeniable that cannabis is trending toward legalization in the United States and many other countries. However, there’s historically been no rapid, portable screening test for cannabis impaired drivers or workers. Gaize is committed to maintaining safety though development of the first objective, accurate, and scientifically defensible screening test for drug impairment.
Poly-Substance Impairment Screening
Studies have shown that alcohol is relatively unique in how it behaves in the body. Other substances cannot be simply measured in the body to determine whether impairment is being experienced. The eyes offer the best solution to discovering active impairment.
Gaize measures micro-movements of the eye, and is based on the existing science of Drug Recognition Expert eye examinations. Tests are performed in an automated fashion, eliminating errors and driving objectivity in evaluations.
Gaize operates at the intersection of cutting edge technology and decades of proven science.
Built with purpose, by people with conviction.
Gaize has been built with a singular goal in mind. We see a world where the inevitable legalization of cannabis and other substances has been met with a technology that keeps roads and workplaces safe. We strongly believe that our approach is uniquely well suited to the challenges that drug impairment presents.
We’re going to succeed because we must.
Ken Fichtler, CEO
Rob Kaufmann, CTO
Dan Zell, Account Executive
Reagan Werner, Business Development
Lou Kratz, Lead Machine Learning Engineer
Apurva Raje, Research Coordinator
JR Plate, Customer Success
Maybe You
We’re hiring, visit our careers page!